SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-20-014498
Filing Date
2020-06-09
Accepted
2020-06-09 16:06:26
Documents
72
Period of Report
2020-04-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0420_enzobiochem.htm 10-Q 723596
2 CERTIFICATION f10q0420ex31-1_enzobio.htm EX-31.1 9411
3 CERTIFICATION f10q0420ex31-2_enzobio.htm EX-31.2 9397
4 CERTIFICATION f10q0420ex32-1_enzobio.htm EX-32.1 3242
5 CERTIFICATION f10q0420ex32-2_enzobio.htm EX-32.2 3381
  Complete submission text file 0001213900-20-014498.txt   4639707

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE enz-20200430.xml EX-101.INS 897141
7 XBRL SCHEMA FILE enz-20200430.xsd EX-101.SCH 61453
8 XBRL CALCULATION FILE enz-20200430_cal.xml EX-101.CAL 36982
9 XBRL DEFINITION FILE enz-20200430_def.xml EX-101.DEF 261714
10 XBRL LABEL FILE enz-20200430_lab.xml EX-101.LAB 503624
11 XBRL PRESENTATION FILE enz-20200430_pre.xml EX-101.PRE 280626
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 001-09974 | Film No.: 20951884
SIC: 8071 Services-Medical Laboratories